HHS awards University of Wisconsin $55.8 million to fight asthma in inner-city children

October 28, 2002

HHS Secretary Tommy G. Thompson today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has awarded a six-year, $55.8 million contract to the University of Wisconsin at Madison. This contract will establish a nationwide research network with the goal of reducing the severity of asthma and preventing the disease in inner-city children, a group that suffers disproportionately from asthma.

"Inadequate access to health care and the best available asthma treatments is one of the reasons for higher rates of asthma and asthma-related deaths in inner-city children," said Secretary Thompson. "The new contract reflects the Department's continuing commitment to addressing this health disparity."

The primary aim of this research network, termed the Inner-City Asthma Consortium (ICAC), is to conduct clinical trials to evaluate the effectiveness of promising immune-based asthma treatments in inner-city children. The effectiveness of currently available asthma treatments may also be tested to make sure they are put to their best use in this population. Finally, the consortium will likely investigate possible genetic predispositions to asthma and the biological mechanisms underlying development of the disease.

The University of Wisconsin at Madison will function as the hub of this research network. Principal investigator and noted asthma researcher William Busse, M.D., and colleagues will coordinate the clinical trials, which will occur at eight sites across the country. The list of sites follows:"The researchers and institutions in this network are the cream of the crop of asthma investigators in this country," said Anthony S. Fauci, NIAID director. "This program combines the skills of investigators experienced in working with inner-city children with asthma, the availability of a pediatric population that may benefit greatly from improved therapy, and the talents of many basic immunologists and clinical researchers."

An additional $14 million over seven years will go to Rho Federal Systems Division, Inc., in Chapel Hill, N.C. This group will collect and analyze the clinical trial data as well as assist with design of the trials and the training and monitoring of site personnel.

Many of the investigators and institutions in the consortium also participate in NIAID's National Cooperative Inner-City Asthma Studies (NCICAS). Launched in 1991 to combat asthma in inner-city children, this network has developed several successful so-called "interventions," public education and outreach methods that have proved to reduce the severity of asthma in inner-city children. Unlike NCICAS, whose goal is to develop new interventions, the new consortium aims to identify promising new asthma medicines through the conduct of clinical trials.

NIAID is a component of the National Institutes of Health (NIH). NIAID supports basic and applied research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, illness from potential agents of bioterrorism, tuberculosis, malaria, autoimmune disorders, asthma and allergies.
-end-


NIH/National Institute of Allergy and Infectious Diseases

Related Asthma Articles from Brightsurf:

Breastfeeding and risks of allergies and asthma
In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.

Researchers make asthma breakthrough
Researchers from Trinity College Dublin have made a breakthrough that may eventually lead to improved therapeutic options for people living with asthma.

Physics vs. asthma
A research team from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases has collaborated with colleagues from the U.S., Canada, France, and Germany to determine the spatial structure of the CysLT1 receptor.

New knowledge on the development of asthma
Researchers at Karolinska Institutet in Sweden have studied which genes are expressed in overactive immune cells in mice with asthma-like inflammation of the airways.

Eating fish may help prevent asthma
A scientist from James Cook University in Australia says an innovative study has revealed new evidence that eating fish can help prevent asthma.

Academic performance of urban children with asthma worse than peers without asthma
A new study published in Annals of Allergy, Asthma and Immunology shows urban children with poorly controlled asthma, particularly those who are ethnic minorities, also suffer academically.

Asthma Controller Step Down Yardstick -- treatment guidance for when asthma improves
The focus for asthma treatment is often stepping up treatment, but clinicians need to know how to step down therapy when symptoms improve.

Asthma management tools improve asthma control and reduce hospital visits
A set of comprehensive asthma management tools helps decrease asthma-related visits to the emergency department, urgent care or hospital and improves patients' asthma control.

Asthma linked to infertility but not among women taking regular asthma preventers
Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to research published in the European Respiratory Journal.

What are the best ways to diagnose and manage asthma?
A team of experts from The University of Texas Medical Branch at Galveston examined the current information available from many different sources on diagnosing and managing mild to moderate asthma in adults and summarized them.

Read More: Asthma News and Asthma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.